ArticleJournal of Cancer2021
TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer.
Keiji Nishibeppu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleJournal of Cancer2021
Keiji Nishibeppu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.